Substance active (DCI)
- paclitaxel (dans une formulation de nanoparticules liées à l’albumine)
Informations techniques
Présentation
PAZENIR 5 mg/mL, poudre pour dispersion pour perfusion
1 flacon en verre de 100 mg (CIP : 34009 301 845 9 2)
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
PSpC2Ux9dbe2mJm2